Search Results 1051-1060 of 16724 for Imiglucerase

1. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

2. OBS in Adolescent and Adults with EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study with an Open Label Extension - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. Cardiovascular Medicine - Clinical trials

   Participants in this study will either have heart failure (HF) and are scheduled to undergo cardiac resynchronization therapy pacemaker (CRT-P) or cardiac ...

4. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

5. Gastroesophageal reflux disease (GERD) - Doctors and departments - Mayo Clinic

   Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

6. Imposter syndrome in PM&R physicians - Mayo Clinic

   Physical medicine and rehabilitation physicians may be especially vulnerable. "PM&R doctors are still underrecognized or unknown to many medical specialties," ...

7. Clinical Trials - Impact of Rapid Detection of MRSA

   The objective of this study is to evaluate the impact of the Alere™ PBP2a test combined with pharmacist review of antimicrobial therapy, on clinical outcomes ...

8. Critical Care - Doctors - Mayo Clinic

   Learn about Mayo Clinic critical care services for people who are critically ill or require advanced ICU monitoring after surgery or trauma.

9. Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Head-to-head comparison between vedolizumab and adalimumab for treatment of moderately to severely active ulcerative colitis - Mayo Clinic

    The Food and Drug Administration approved the use of anti-tumor necrosis factor and anti-integrin agents for the treatment of ulcerative colitis in 2005 ...